Mill Creek Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mill Creek Capital Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Hold	2,121	–	–	0.01%	220
2025 Q4	$259K	Hold	2,121	–	–	0.01%	227
2025 Q3	$213K	Buy	+2,121	New	+$191K	﹤0.01%	261
2025 Q2	–	Sell	-6,767	Closed	-$549K	–	275
2025 Q1	$549K	Hold	6,767	–	–	0.01%	149
2024 Q4	$609K	Sell	6,767 -218	-3%	-$21.1K	0.01%	150
2024 Q3	$690K	Sell	6,985 -2,732	-28%	-$268K	0.02%	141
2024 Q2	$901K	Buy	9,717 +7,596	+358%	+$681K	0.02%	122
2024 Q1	$201K	Sell	2,121 -643	-23%	-$59.7K	0.01%	229
2023 Q4	$247K	Hold	2,764	–	–	0.01%	210
2023 Q3	$202K	Hold	2,764	–	–	0.01%	212
2023 Q2	$230K	Hold	2,764	–	–	0.01%	216
2023 Q1	$211K	Hold	2,764	–	–	0.01%	225
2022 Q4	$229K	Buy	+2,764	New	+$224K	0.01%	202

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mill Creek Capital Advisors's XBI Position: Q1 2026 in Review

Mill Creek Capital Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,121 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #220.

Mill Creek Capital Advisors first reported a position in XBI in Q4 2022 and has held it in 13 quarters since. The position peaked at $901K in Q2 2024. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Mill Creek Capital Advisors held 2,121 shares of State Street SPDR S&P Biotech ETF worth $271K as of Q1 2026.
Mill Creek Capital Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #220 holding.
Mill Creek Capital Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 13 quarters since.
Mill Creek Capital Advisors's State Street SPDR S&P Biotech ETF position peaked at $901K in Q2 2024.
816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.